US EditionPublished • loading... • Updated
US awards no-bid contract to Denmark scientists studying hepatitis B vaccine in African babies
The $1.6 million contract funds a five-year trial tracking 14,000 newborns to study effects of withholding the hepatitis B vaccine birth dose in Guinea-Bissau.
- The Trump administration awarded a $1.6 million no-bid contract to a Danish university for studying hepatitis B vaccinations in newborns in Africa, raising ethical concerns.
- Experts raised ethical concerns about the research plan, arguing it would withhold effective vaccines from high-risk newborns.
- The Associated Press reported that the contract did not undergo a customary ethics review.
- CDC staff expressed outrage over the award in private communications, according to an official who spoke anonymously.
Insights by Ground AI
21 Articles
21 Articles
First, the USA withdrew a recommendation for newborns against hepatitis B. Now they are funding a study with the vaccine in Guinea-Bissau. Critics describe the procedure as "unethical".
·Germany
Read Full Article
U.S. awards no-bid contract to Denmark scientists studying hepatitis B vaccine in African babies
The Trump administration has awarded a $1.6 million, no-bid contract to a Danish university to study hepatitis B vaccinations on newborns in Africa that is raising ethical concerns.
·United States
Read Full Article
Associated Press News+18 Reposted by 18 other sources
US awards no-bid contract to Denmark scientists studying hepatitis B vaccine in African babies
The Trump administration has awarded a $1.6 million, no-bid contract a Danish university to study hepatitis B vaccinations on newborns in Africa.
·United States
Read Full ArticleCoverage Details
Total News Sources21
Leaning Left8Leaning Right2Center9Last UpdatedBias Distribution47% Center
Bias Distribution
- 47% of the sources are Center
47% Center
L 42%
C 47%
11%
Factuality
To view factuality data please Upgrade to Premium
